AT69637B - Process for the preparation of therapeutically active substances. - Google Patents

Process for the preparation of therapeutically active substances.

Info

Publication number
AT69637B
AT69637B AT69637DA AT69637B AT 69637 B AT69637 B AT 69637B AT 69637D A AT69637D A AT 69637DA AT 69637 B AT69637 B AT 69637B
Authority
AT
Austria
Prior art keywords
preparation
active substances
therapeutically active
bile
substances
Prior art date
Application number
Other languages
German (de)
Inventor
Richard Dr Med Noehring
Original Assignee
Richard Dr Med Noehring
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richard Dr Med Noehring filed Critical Richard Dr Med Noehring
Application granted granted Critical
Publication of AT69637B publication Critical patent/AT69637B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

   <Desc/Clms Page number 1> 
 



  Verfahren zur Darstellung therapeutisch wirksamer Substanzen. 



   Die Gallensubstanz besteht aus einem Gemenge von teils bekannten, teils unbekannten Stoffen. Die Gesamtmenge dieser Stoffe ist für den tierischen Organismus toxisch. 



   Das vorliegende Verfahren hat nun den Zweck, die therapeutisch wertvollen Substanzen der Galle zu isolieren. Es besteht darin, dass man frische Galle-zweckmässig in verdiinntem Zustande-mit Säure versetzt, von dem ausgefällten Farbstoff und Gallensäuren abfiltriert und aus dem Filtrat mit Alkalien die wirksame Substanz in fester Form abscheidet. Das so erhaltene Produkt besitzt die Eigenschaft, für normale Organismen so gut wie ungiftig zu sein, während es für pathologisch veränderte Organismen toxische Wirkungen besitzt, die sich beispielsweise bei tuberkulös erkrankten Organismen in einer ausgesprochenen Herdreaktion äussern. 



   Beispiel :
100 g Galle werden mit 400 g Wasser verdünnt und mit   20 9 Salzsäure   versetzt. 



  Das Gemenge wired filtriert und die gebuchte Substanz aus dem Filtrat mit Natronlauge   ausgefällt. Die   wirksame   Substanz   scheidet sich in Form eines Niederschlages a) und wird durch Abfiltrierung, Umlösen mit Salzsäjre und Wiederausfällen mit Natronlauge sowie durch Auswaschen mit destilliertem Wasser als leicht bräunlich gefärbtes Pulver erhalten. 



   An Stelle von Natronlauge   körner   zur Fallung andere Alkalien und Basen verwendet worden. 

**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.



   <Desc / Clms Page number 1>
 



  Process for the preparation of therapeutically active substances.



   The bile substance consists of a mixture of partly known and partly unknown substances. The total amount of these substances is toxic to the animal organism.



   The present method now has the purpose of isolating the therapeutically valuable substances of the bile. It consists in adding acid to fresh bile - expediently in a diluted state - filtering off the precipitated dye and bile acids and separating the active substance in solid form from the filtrate with alkalis. The product obtained in this way has the property of being as good as nontoxic for normal organisms, while it has toxic effects for pathologically altered organisms which, for example, manifest themselves in a pronounced focal reaction in organisms with tuberculosis.



   Example:
100 g of bile are diluted with 400 g of water and 20 g of hydrochloric acid are added.



  The mixture is filtered and the booked substance is precipitated from the filtrate with sodium hydroxide solution. The active substance separates in the form of a precipitate a) and is obtained as a slightly brownish powder by filtering off, dissolving with hydrochloric acid and reprecipitating with sodium hydroxide solution and washing with distilled water.



   Instead of caustic soda grains, other alkalis and bases have been used for precipitation.

** WARNING ** End of DESC field may overlap beginning of CLMS **.

 

Claims (1)

PATENT-ANSPRUCH : Verfahren zur Darstellung einer therapeutisch wirksamen Substanz, darin bestehend, dass man Galle-zweckmässig in verdünntem Zustande-mit Säure behandelt, von dem ausgefälltem Farbstoffe usw. abfiltriert und aus dem Filtrat mit Alkalien die wirksamen Substanzen in fester Form abscheidet. **WARNUNG** Ende CLMS Feld Kannt Anfang DESC uberlappen**. PATENT CLAIM: Process for the preparation of a therapeutically active substance, consisting in treating bile with acid, expediently in a diluted state, filtering off the precipitated coloring matter etc. and separating the active substances in solid form from the filtrate with alkalis. ** WARNING ** End of CLMS field may overlap beginning of DESC **.
AT69637D 1913-06-13 1914-05-16 Process for the preparation of therapeutically active substances. AT69637B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE69637X 1913-06-13

Publications (1)

Publication Number Publication Date
AT69637B true AT69637B (en) 1915-08-25

Family

ID=5635091

Family Applications (1)

Application Number Title Priority Date Filing Date
AT69637D AT69637B (en) 1913-06-13 1914-05-16 Process for the preparation of therapeutically active substances.

Country Status (1)

Country Link
AT (1) AT69637B (en)

Similar Documents

Publication Publication Date Title
AT69637B (en) Process for the preparation of therapeutically active substances.
DE444734C (en) Process for the production of aluminum salts of organic acids
AT110280B (en) Process for the production of water-soluble anthraquinone glycosides from drugs.
DE402514C (en) Process for the production of colloidal substances
DE933450C (en) Process for the preparation of a new salt of penicillin G.
DE212830C (en)
DE619348C (en) Process for the production of pure diacetyl from wood vinegar or other mixtures containing diacetyl
AT150297B (en) Process for the preparation of unsymmetrical aromatic arsenic compounds.
DE515468C (en) Process for the preparation of ª ‰ -Naphthylaminophenoxyfettsaeuren
DE948735C (en) Process for obtaining a therapeutically active substance from organisms of the classes Crustacea and Myriapoda
AT225349B (en) Process for the preparation of pure solutions of the kallikrein inactivator
DE444388C (en) Process for the preparation of tasteless alkaloid preparations
DE558567C (en) Process for the production of soluble particles of organic antimony compounds
AT146967B (en) Process for the production of heavy metal compounds of the porphine series.
DE284231C (en)
AT117492B (en) Process for the preparation of w-aminoalkylaminonaphthalenecarboxylic acids.
DE188435C (en)
AT206580B (en)
DE267126C (en)
DE663380C (en) Process for the production of therapeutically valuable gold compounds from keratin breakdown products
DE961802C (en) Process for the preparation of tetra- and hexahydrocarbomycin
AT153500B (en) Process for the preparation of compounds of sulfhydryl keratinic acid.
AT94306B (en) Process for the separation of o- and p-toluenesulfamide.
DE1569604C3 (en) Process for the preparation of basic oxazine dyes
DE585519C (en) Process for the preparation of organic bismuth compounds